Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL188002

C[N+](C)(C)CCO.O=C([O-])C(O)C(O)C(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GBA1 known ✓ P04062 1/20 0.32
LMNA P02545 3/20 0.46
CYP3A4 P08684 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC5A7 Q9GZV3 1/20 0.46
TSHR P16473 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
SLC22A16 Q86VW1 1/20 0.36
GALR3 O60755 1/20 0.33
CYP2C9 P11712 1/20 0.33
PDE4A P27815 1/20 0.33
MAPT P10636 1/20 0.32
ALPL P05186 1/20 0.31
POLB P06746 1/20 0.31
ALPG P10696 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL5311459 1.00 LMNA (0.46) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL8167949 1.00 LMNA (0.46) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL9581037 1.00 LMNA (0.46) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL2586847 1.00 LMNA (0.46) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL28683781 0.98 LMNA (0.44) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL9296176 0.98 CYP3A4 (0.50) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL15993811 0.94 LMNA (0.41) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL14856284 0.94 LMNA (0.41) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL30402903 0.94 LMNA (0.52) LMNACYP3A4MEN1KMT2ASLC5A7
Cadaverine Tartrate SCHEMBL188000 0.94 LMNA (0.52) LMNACYP3A4MEN1KMT2ASLC5A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6466 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401580-B1 SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES NUTRICIA NV (NL) 2026-05-27 EP claimed
EP-4748443-A2 SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES N.V. Nutricia (NL) 2026-05-27 EP claimed
CN-122036984-A Process for extracting dendrobium candidum polysaccharide based on deep eutectic solvent 江西省林业科学院 2026-05-15 CN claimed
US-20260130850-A1 TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF LIFEACTIVE INC (US) 2026-05-14 US claimed
CN-119614203-B Etching solution for selectively etching silicon nitride and silicon oxide and titanium nitride 湖北兴福电子材料股份有限公司 2026-05-12 CN claimed
US-20260123659-A1 NUTRITIONAL FORMULA BUILDING BLOCK NUTRITIONALS LLC (US) 2026-05-07 US claimed
US-12616233-B2 Infant formula composition and methods of manufacture The Bêne Baby Company LLC (US) 2026-05-05 US claimed
US-20260117409-A1 COMPOSITION FOR PLATING METAL COATINGS AND METHODS OF MAKING AND USING THE SAME BATTELLE MEMORIAL INSTITUTE (US) 2026-04-30 US claimed
US-20260101917-A1 Hydrolyzed Pea Protein-Based Nutrient Composition KATE FARMS INC (US) 2026-04-16 US claimed
EP-4724101-A1 TRANSDERMAL DELIVERY FORMULATIONS Lifeactive, Inc. (US) 2026-04-15 EP claimed
US-4988517-A ANTITUMOR AGENTS, BENZYLSELENOCYANATE, INCREASING GLUTATHIONE PEROXIDASE AMERICAN HEALTH FOUNDATION (US) 1991-01-29 US claimed
EP-0389667-A2 Use of lecithin to restore olfaction and taste PHARMACAPS, INC. (US) 1990-10-03 EP claimed
US-4948589-A CHOLINE COATED WITH HYDROPHOBIC FILM FOR DELAYED DISSOLVING SHOWA DENKO KABUSHIKI KAISHA (JP) 1990-08-14 US claimed
US-4917685-A POROUS MEMBRANE CONFINING ACTIVE MATERIALS AND STABILIZERS INTERNATIONAL MINERALS & CHEM. CORP. 1990-04-17 US claimed
US-4837219-A Medication for Alzheimer's disease HUTTERER JEFFREY (US) 1989-06-06 US claimed
US-4816568-A AMINO ACIDS, POLYPEPTIDES, CHOLINE SALTS INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1989-03-28 US claimed
EP-0303746-A1 Stabilization of growth promoting hormones Mallinckrodt Group Inc. (US) 1989-02-22 EP claimed
EP-0146017-A1 Plant growth regulator and method for increasing crop yields and promoting root formation MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1985-06-26 EP claimed
US-4499076-A AMINO ACIDS, CARBOHYDRATES FATS, VITAMINS AND MINERALS AJINOMOTO COMPANY INCORPORATED (JP) 1985-02-12 US claimed
US-4497800-A Stable liquid diet composition MEAD JOHNSON & COMPANY (US) 1985-02-05 US claimed